Global Video Telemedicine Market is Witnessing Significant Growth as industry leader VSee lab Inc. partners with Vuzix Corporation to introduce an innovative telemedicine product

 

Video Telemedicine Market

Video telemedicine uses technology primarily computers, video, messaging, and phone by medical professionals to diagnose and treat patients in remote locations. Video telemedicine or telemedicine involves the use of electronic communications and software for management of chronic conditions. 

Increasing prevalence of hospital-acquired infection and increasing incidences of white coat syndrome is expected to drive growth of the global video telemedicine market during the forecast period. According to the Indian Journal Medical Research (IJMR), in 2017, surgical-site infections (SSIs) were the most common HAI with prevalence of 23.94% followed by hospital-acquired pneumonia with 18.31%, catheter-related blood stream infection (16.9%), and urinary tract infections (16.9%) in India. Such high prevalence has led to increase in demand for video telemedicine globally. Video telemedicine offers numerous advantages such as less time in waiting room, no transportation time and cost, and fewer chances of catching a new illness. Thus, these factors are expected to drive growth of the global video telemedicine market during the forecast period. Moreover, growing geriatric population is expected to boost the global video telemedicine market growth over the forecast period. According to the World Health Organization (WHO), by 2050, global population of aged 60 years and above is expected to reach 2 billion, increasing from 900 million in 2015. Video telemedicine is a perfect alternative to geriatric people to get medical treatments and medications without actually visiting the doctor’s office.

However, lack of skilled personnel and adequate infrastructure is expected to restrain growth of the global video telemedicine market during the forecast period. Besides, lack of awareness regarding the technology in emerging economies is expected to hinder the global video telemedicine market growth in the near future. Among regions, North America is expected to witness significant growth in the global video telemedicine market during the forecast period. This is owing to wide implementation of video telemedicine and increasing demand for unnecessary transpiration. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing patient pool and healthcare practitioners in the region.

Key companies operating in the global video telemedicine market are Life-Size Communication Inc., Vidyo Inc., Vermont Tel, Sony Corporation, Huawei Technologies Co Ltd., GlobalMed Inc., Premiere Global Services Inc., and VSee lab Inc.

For instance, in November 2020, Vuzix Corporation partnered with VSee lab Inc., a U.S.-based telehealth company to introduce a telehealth and telemedicine smart glasses solution Vuzix Blade Smart Glasses and Vuzix' M300XL. 

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the deman
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cance
Read more